Cancer genomics pioneer Prof Sir Mike Stratton has been awarded the 2026 Jessie Stevenson Kovalenko Medal by the Council of ...

Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...

On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer samples into high-resolution, multimodal datasets, backed by £18.9 million in ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

Do microorganisms truly reside in tumors, or do the samples become contaminated before sequencing occurs? A new computational ...

Cancer is no longer seen as a single genetic error but as a complex, multi-layered disease shaped by DNA mutations, epigenetic changes and even patterns in medical images. New research at ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research ...

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial ...

On April 13, 2023, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine will convene a virtual, public workshop to explore the state of the science with ...

The initiative aims to bridge critical genomic data gaps and enable early diagnosis, personalised cancer treatment, and ...

Cancer genomics has revolutionised our understanding of tumour biology by deciphering the complex genetic alterations that underpin oncogenesis. Central to this field is the identification and ...